SABBY 13G SRPT 04.24.13

Company

Sarepta Therapeutics, Inc.

Filed

April 24, 2013

Accession Number

0001535610-13-000036

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →